Companies: 10,795·Total market cap: $144.5T
bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.

BIAFNASDAQHealthcare● Active
$1.60
$-0.13(-7.51%)
Market Cap$7255850
P/E Ratio
52W High$13.8
52W Low$0.693

bioAffinity Technologies, Inc.(BIAF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BIAF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$6.16M$9.36M$2.53M$0.00M$0.00M
Cost of Revenue$4.73M$5.98M$1.74M$0.00M$0.00M
Gross Profit$1.43M$3.38M$0.79M$0.00M($0.00M)
Gross Margin %(computed)23.21%36.09%31.26%90.28%
Operating Expenses
R&D Expenses$2.09M$1.78M$1.73M$1.52M$1.14M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.88M
Total Operating Expenses$12.00M$12.33M$8.77M$4.02M$2.20M
Operating Income($10.57M)($8.95M)($7.97M)($4.01M)($2.21M)
Operating Margin %(computed)-171.58%-95.63%-314.89%
Interest Income$0.02M$0.02M$0.12M$0.05M$0.00M
Interest Expense$0.04M$0.09M$0.04M$2.53M$1.00M
Income Before Tax($14.87M)($9.03M)($7.92M)($8.15M)($6.32M)
Income Tax Expense$0.04M$0.01M$0.02M$0.00M$0.00M
Net Income($14.91M)($9.04M)($7.94M)($8.15M)($6.33M)
Net Margin %(computed)-241.96%-96.56%-313.47%
Per Share & EBITDA
EPS (Basic)$-8.66$-22.50$-27.30$-54.30$-70.86
Wtd Avg Shares1.72M0.40M0.29M0.15M0.09M
EBITDA($10.07M)($8.33M)($7.63M)($5.61M)($5.32M)
EBITDA Margin %(computed)-163.38%-88.98%-301.30%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解bioAffinity Technologies, Inc.

关于bioAffinity Technologies, Inc.(BIAF)损益表

bioAffinity Technologies, Inc.(BIAF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BIAF实现营收$0.01B,毛利润$0.00B(毛利率23.21%),净利润($0.01B)(净利率-241.96%)。

常见问题

BIAF · 4 问

bioAffinity Technologies, Inc.(BIAF)2025财年营收为$0.01B,同比down34.2%。

BIAF revenueBIAF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09